Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstrom's Macroglobulinemia
NCT01046006Phase 2Completed
- Start
- Mar 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules, Modified Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of bortezomib in Waldenstrom macroglobulinemia (WM). Started Mar 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
Waldenstrom macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT01046006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046006.